Clinical Trial Update: Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

View source ↗

Summary

Takeda outlines a post-trial access program for idursulfase-IT together with Elaprase to treat children with Hunter syndrome. The update describes continued acc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Ii

Drugs mentioned

• Elaprase (idursulfase)
• Idursulfase-IT (idursulfase-IT)

Snippet

Sponsor: Takeda | Conditions: Hunter Syndrome | Status: AVAILABLE